![Doug Melancon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Doug Melancon
Direttore/Membro del Consiglio presso
Arthur Ashe Institute for Urban Health
Profilo
Douglas Melancon is currently Managing Director at Advent Capital Management LLC since 2004 and Director at Arthur Ashe Institute for Urban Health.
Former positions include Senior Healthcare Analyst at Robeco Weiss, Peck & Greer Investments from 2000 to 2001, Portfolio Manager at Merlin Biomed Group Hedge Funds from 2001 to 2004, Vice President roles at Advent Convertible & Income Fund, Advent Claymore Global Convertible Securities & Income Fund, and Advent, as well as Analyst roles at Merrill Lynch, Pierce, Fenner & Smith, Inc. and Morgan Stanley & Co. LLC.
Education includes a doctorate from the University of Pennsylvania in 1994, and an undergraduate degree in 1988 and an MBA in 1990 from the University of Illinois.
Posizioni attive di Doug Melancon
| Società | Posizione | Inizio |
|---|---|---|
Advent Capital Management LLC
 Advent Capital Management LLC Investment ManagersFinance Advent is a bottom-up, fundamental credit firm focused on cash flow, interest coverage, and balance sheet analysis. The firm seeks to achieve consistent and frequent returns while generating alpha across all of their strategies through a demonstrated investment discipline. | Gestore di Portafoglio-Azioni | 01/02/2004 |
Arthur Ashe Institute for Urban Health
 Arthur Ashe Institute for Urban Health Medical/Nursing ServicesHealth Services Provides healthcare services | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Doug Melancon
| Società | Posizione | Fine |
|---|---|---|
Merlin Biomed Group Hedge Funds
 Merlin Biomed Group Hedge Funds Investment ManagersFinance Merlin BioMed invests globally in public and private healthcare companies. The firm's hedge funds and long-term appreciation fund seek maximum capital appreciation from broad-based, global investment in small-, mid- and large-cap public and private companies in the areas of biotechnology, pharmaceuticals, medical devices, healthcare services and research products/services. This investment objective is characterized by an intensive, research-oriented, fundamental, bottom-up approach with a focus on new product innovation as a driver of sales and earnings growth. For private equity, the MerlinNexus objective is to realize long-term capital appreciation from investments in late-stage private companies, PIPEs (private investments in public entities) and select open market transactions. The fund is invested in all segments of the healthcare industry, with an emphasis on product-driven life sciences companies developing breakthrough products that meet clinical needs and can positively alter disease course and associated costs. | Analyst-Equity | - |
Robeco Weiss, Peck & Greer Investments
 Robeco Weiss, Peck & Greer Investments Investment ManagersFinance Robeco Weiss Peck & Greer Investment provides a broad range of product offerings, including taxable and tax-exempt fixed-income (both investment grade and below investment grade), equity and alternative investment strategies. Products are managed by individual specialized investment teams, each following its own disciplined investment philosophy, process and approach. Investment strategies are offered through separate accounts and commingled and mutual funds, the Robeco Investment Funds. | Analyst-Equity | - |
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
 Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Advent Claymore Global Convertible Securities & Income Fund
 Advent Claymore Global Convertible Securities & Income Fund Investment Trusts/Mutual FundsMiscellaneous Closed-End Investment Fund/Investment Trust | Corporate Officer/Principal | - |
Advent/Claymore Enhanced Growth & Income Fund
 Advent/Claymore Enhanced Growth & Income Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Corporate Officer/Principal | - |
Formazione di Doug Melancon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
95
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Robeco Weiss, Peck & Greer Investments
Robeco Weiss, Peck & Greer Investments Investment ManagersFinance Robeco Weiss Peck & Greer Investment provides a broad range of product offerings, including taxable and tax-exempt fixed-income (both investment grade and below investment grade), equity and alternative investment strategies. Products are managed by individual specialized investment teams, each following its own disciplined investment philosophy, process and approach. Investment strategies are offered through separate accounts and commingled and mutual funds, the Robeco Investment Funds. | Finance |
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Provides brokerage services | Finance |
Advent Capital Management LLC
Advent Capital Management LLC Investment ManagersFinance Advent is a bottom-up, fundamental credit firm focused on cash flow, interest coverage, and balance sheet analysis. The firm seeks to achieve consistent and frequent returns while generating alpha across all of their strategies through a demonstrated investment discipline. | Finance |
Merlin Biomed Group Hedge Funds
Merlin Biomed Group Hedge Funds Investment ManagersFinance Merlin BioMed invests globally in public and private healthcare companies. The firm's hedge funds and long-term appreciation fund seek maximum capital appreciation from broad-based, global investment in small-, mid- and large-cap public and private companies in the areas of biotechnology, pharmaceuticals, medical devices, healthcare services and research products/services. This investment objective is characterized by an intensive, research-oriented, fundamental, bottom-up approach with a focus on new product innovation as a driver of sales and earnings growth. For private equity, the MerlinNexus objective is to realize long-term capital appreciation from investments in late-stage private companies, PIPEs (private investments in public entities) and select open market transactions. The fund is invested in all segments of the healthcare industry, with an emphasis on product-driven life sciences companies developing breakthrough products that meet clinical needs and can positively alter disease course and associated costs. | Finance |
Advent Convertible & Income Fund
 Advent Convertible & Income Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Advent/Claymore Enhanced Growth & Income Fund
Advent/Claymore Enhanced Growth & Income Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advent Claymore Global Convertible Securities & Income Fund
Advent Claymore Global Convertible Securities & Income Fund Investment Trusts/Mutual FundsMiscellaneous Closed-End Investment Fund/Investment Trust | Miscellaneous |
Arthur Ashe Institute for Urban Health
Arthur Ashe Institute for Urban Health Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
